Follow-On Offering

Healthcare
Follow-On Offering

Summary

Baird served as co-manager on this transaction.

About

AMAG Pharmaceuticals, Inc. (“AMAG” or the “Company”) (NASDAQ-GS: AMAG) recently completed a follow-on offering of approximately 4,600,000 shares of common stock at a price of $44.00 per share, generating gross proceeds of approximately $200 million. The Company intends to use the net proceeds from the offering for general corporate purposes.

AMAG is a rapidly growing, specialty pharmaceutical company, supported by a talented and passionate workforce with a focus on maternal health, anemia and cancer supportive care. AMAG is headquartered in Waltham, Massachusetts.

For additional information about this transaction, please contact:

David Schechner +1 (617) 426-5424
Lance Lange +1 (414) 765-7079
Satoshi Matsumoto +1 (312) 609-5446
Vipul Patel +1 (312) 609-4933
Brian Thomas +1 (415) 627-3275
Healthcare
Follow-On Offering
Date
March 2015
Company
AMAG Pharmaceuticals, Inc.
Transaction
M&A
Sectors
Healthcare
Target Location
North America

Share